Co-Diagnostics, Inc.
CODX
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, denguā¦ read more
Healthcare
Medical Devices
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.41
Price+3.05%
$0.02
1Y
Price
Market Cap
$12.737m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-4767.3%
EBITDA Margin-4745.0%
Net Profit Margin-5333.5%
Free Cash Flow MarginRevenue
$1.004m
-74.4%
1y CAGR-65.7%
3y CAGR-65.5%
5y CAGREarnings
-$35.991m
+4.4%
1y CAGR-50.1%
3y CAGR-72.3%
5y CAGREPS
-$1.12
+9.7%
1y CAGR-53.4%
3y CAGR-74.2%
5y CAGRBook Value
$41.138m
$46.466m
Assets$5.327m
Liabilities$1.704m
DebtDebt to Assets
3.7%
-
Debt to EBITDAFree Cash Flow
-$33.234m
-11.1%
1y CAGR-198.2%
3y CAGR-170.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company